Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangkui Capsule for Chronic Kidney Disease
NCT02231138Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Sep 2014
- Primary completion
- Jan 2016
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of huang kui capsule in chronic kidney disease (CKD), sponsored by Chinese PLA General Hospital. Primary endpoint: Change in 24-h proteinuria at 24 weeks. Status: unknown.
02
Drugs
huang kui capsule
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02231138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231138.